Why 7 Hours Of Sleep Feels Better In Japan Than In The US
He highlighted seven major differences between Japanese and American sleep patterns, which caused everyone to re-evaluate their entire bedtime ritual.
Sleep is a crucial component of overall health and well-being. It's not just about feeling rested, but also about allowing your body and mind to repair, consolidate memories, and regulate various bodily functions. But have you ever noticed that sometimes you wake up feeling fresh even after just 6 hours of sleep and sometimes don't even want to step out of your room after getting 7 to 8 hours of sleep too?
Recently, a former investment banker broke down why this happens. 'You sleep 7 hours in Japan and wake up energised and healthy. In America, the same 7 hours leave you exhausted and reaching for coffee. And no one talks about why," he wrote on X.
He highlighted seven major differences between Japanese and American sleep patterns, which caused everyone to re-evaluate their entire bedtime ritual.
What's the Difference?
Room Temperature:
Mattress
You might not have noticed, but the mattress you sleep on plays a crucial role in getting a good sleep. As per Jay, in the US, people use softer mattresses and that comfy feeling might be the reason you're waking up with a stiff back or neck.
In Japan, firm sleeping surfaces, such as futons on the floor, are still common. These more rigid positions help to maintain proper posture and support the spine while you sleep.
Hot Bath
In Japan, people often take a warm bath before heading to bed. After soaking in warm water, the body temperature somewhat decreases and signals the brain that it's time to sleep. Not just this, a warm bath also helps in relaxing muscles and removing stress.
Pillows
In Japan, sobakawa buckwheat pillows are used for sleeping. They are compact, strong, and incredibly helpful. The inside hulls adapt to the curves of your neck, maintaining the right alignment of your spine throughout the night. In comparison, many Americans use big, fluffy pillows that may feel good at first but frequently push their head forward, causing neck posture problems.
Limited Tech Use
The research discovered that in Japan, people are more mindful about how and when to use the smartphone and there are clear boundaries; No binge-watching or phone scrolling before bed.
But in the US, people tend to check their emails and Insta DMs before lights out. It's overstimulating and messes with our ability to relax. Your brain stays wired long after you've set the phone down.
Therefore, it is important to be mindful of your sleep as it profoundly impacts both your physical and mental well-being.
Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Can cancer drugs treat Alzheimer's? New study thinks so
Alzheimer's disease, a progressive neurodegenerative disorder that primarily affects memory and cognitive functions, is the most common cause of dementia, accounting for 60-70% of dementia cases. As per Alzheimer's Association, in 2025, global Alzheimer's statistics indicate a significant prevalence of the disease, with projections estimating that over 7 million Americans will be living with Alzheimer's dementia. Globally, it is estimated that someone develops dementia every three seconds, and the number of people living with dementia is expected to reach 78 million by 2030. The progressive neurodegenerative disorder, long considered a therapeutic dead end, may soon find some hope of cure in an unlikely ally: cancer drugs. Recent research reveals that several oncology medications, originally designed to fight tumors, have shown promise in targeting key pathways of Alzheimer's disease (AD), from protein aggregation to neuroinflammation and metabolic dysfunction. Let's delve deeper into the newest discovery of the silver lining. The medical breakthrough: Scientists are exploring cancer drugs as a potential way to tackle Alzheimer's disease, given that the options for treatment are quite limited. As cases of Alzheimer's continue to rise in the U.S. and around the world due to an aging population, there still isn't a cure. Efforts to create new treatments that actually slow the disease's progression have mostly fallen short. Currently, only two drugs, Leqembi and Kisunla, are approved by the FDA to slow down early Alzheimer's, but their effectiveness is very limited. Many pharmaceutical companies have even stopped developing Alzheimer's drugs after unsuccessful trials, while others are experimenting with existing medications, including popular weight loss drugs. Researchers at the University of California, San Francisco, have taken a different approach. They searched through a database of over 1,300 various drugs, like antipsychotics and chemotherapy drugs, to find ones that could be repurposed for Alzheimer's treatment. Their study, published in the journal Cell , highlighted two cancer drugs that showed promise in reducing Alzheimer's risk. When tested together on mice, these drugs appeared to slow or even reverse Alzheimer's symptoms. One drug is typically used for breast cancer, and the other works against colon and lung cancer. Alzheimer's is known to cause significant changes in gene expression in the brain, which can disrupt brain function and lead to memory loss. From their database, fewer than 90 drugs successfully reversed markers related to Alzheimer's in human brain cells. Of these, five drugs seemed particularly effective in lowering Alzheimer's risk for actual patients, and the researchers focused on two FDA-approved cancer drugs to test in mice. According to the findings, letrozole, a breast cancer drug, appeared to influence gene expression in nerve cells, while irinotecan, used for colon and lung cancer, affected glial cells, which support the nervous system. Alzheimer's can damage nerve cells and trigger an overgrowth of glial cells, leading to brain inflammation. Interestingly, past studies have shown that breast cancer patients on letrozole had a lower chance of developing Alzheimer's, and colorectal cancer survivors treated with irinotecan also showed decreased risk, adding to the excitement around these findings. The groundbreaking findings: Researchers have been testing a combination of two cancer drugs in mice and found some promising results: the combo reversed brain degeneration and improved memory in mice showing signs of Alzheimer's. However, because what works in mice doesn't always work in humans, they plan to test these drugs in a clinical trial with Alzheimer's patients. Dr. Yadong Huang, a co-author of the study and a neurology professor at UCSF, noted the advantages of repurposing existing drugs: 'Developing a new drug can take hundreds of millions, or even billions, of dollars, and on average takes more than 10 years. For this repurposed drug, usually, it just takes two or three years, and then you can go to the clinical trial, and the cost is much, much lower.' Despite this progress, he acknowledged, as reported by NBC News, 'We still haven't generated or produced any very effective drugs that can really slow down dramatically the cognitive decline. ' Alzheimer's remains a complex disease, and its exact cause is still a mystery. Currently, it isn't clear why these cancer drugs might help with Alzheimer's. One idea is that the breast cancer drug reduces estrogen production, which controls many genes. Another theory is that the colon and lung cancer drug might reduce inflammation in the brain by stopping glial cells from multiplying. Dr. Melanie McReynolds, a biochemistry assistant professor at Pennsylvania State University, who wasn't involved in this study, added another angle. Her research suggests that another cancer drug can help Alzheimer's by regulating glucose metabolism, which is how cells generate energy. 'With aging, with stress, with diseases, that line of communication is disrupted,' she explained. She believes the drug combo could reverse metabolic decline, calling it 'the secret for contributing to better outcomes with Alzheimer's. ' What's ahead: Cancer drug repurposing opens a transformative chapter in Alzheimer's treatment, where repurposing anticancer agents allows researchers to exploit existing toxicity and pharmacokinetic data, potentially accelerating human testing and reducing development costs. While these findings are exciting, the potential side effects need to be carefully considered. Letrozole can cause hot flashes, and irinotecan may lead to severe diarrhea. 'These drugs have huge side effects, so you need to always balance and figure out whether those types of side effects would be amenable to somebody with Alzheimer's,' Sirota cautioned. 'It's not that it's a slam dunk.' Reduced risk of Alzheimer's disease linked to target protein for diabetes, as per a study
Time of India
an hour ago
- Time of India
Coldwater creek and cancer risk explained by Harvard experts: Why this small stream in the US linked to cancer
Image: Istock Coldwater Creek, a stream winding through north St. Louis County, Missouri, is getting global attention. Turns out, this peaceful-looking waterway has a dark past. Due to radioactive waste dumped nearby during the World War II Manhattan Project (the one that made atomic bombs), the creek has been quietly soaking up toxic leftovers for decades. So what went wrong? Back in the 1940s, uranium waste from bomb-making was poorly stored around Lambert Airport. Over time, it made its way into Coldwater Creek—through runoff, careless dumping, and just plain neglect. That waste included stuff like thorium-230, a radioactive byproduct that sticks around forever. For most of the 20th century, the problem was ignored. Only in the 1990s did the US Army Corps of Engineers start cleaning things up, and it might not be fully done until 2038 (yes, seriously). What does Harvard say? A major Harvard study just dropped in JAMA Network Open (July 2025), and it's not good news. Researchers followed over 4,000 folks from the St. Louis Baby Tooth study—kids from the 1950s–70s who lived nearby and donated teeth to test for nuclear fallout. By linking those records to self-reported health issues, the study found that kids who grew up within 1 km of Coldwater Creek were 44% more likely to develop any kind of cancer later in life. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like American Investor Warren Buffett Recommends: 5 Books For Turning Your Life Around Blinkist: Warren Buffett's Reading List Undo But that's just the beginning. The odds shot up even more for radiosensitive cancers—think thyroid cancer, leukemia, breast cancer, and bone cancer. For thyroid cancer alone, the risk was 5 times higher in people who lived closest to the creek as kids. Participants who lived within 1 kilometer of Coldwater Creek during childhood showed a 44% higher odds (OR = 1.44; 95% CI, 0.96–2.14) of developing any form of cancer compared to those living more than 20 kilometers away, though this result bordered on statistical significance. The association was stronger for radiosensitive cancers—those linked scientifically to radiation exposure with an odds ratio of 1.85 (95% CI, 1.21–2.81) for those living closest to the creek versus the furthest. For thyroid cancer, the risk was particularly elevated (OR = 5.00; 95% CI, 1.23–20.32) Harvard epidemiologists, led by Prof. Marc Weisskopf, emphasized the broader implications of exposure to low-level radioactive waste from nuclear projects, warning that similar risks could emerge as nuclear power and weapons programs expand worldwide What cancers are we talking about? Thyroid cancer Leukemia Brain tumors Bone cancer Lung cancer Even federal agencies like the US Agency for Toxic Substances and Disease Registry are backing this up. They say anyone who lived or played near the creek from the 1960s to the 1990s could face higher cancer risks. The takeaway? The closer you lived to Coldwater Creek—and the longer you were there—the higher your chances of developing cancer. It's a textbook case of radiation exposure risks, and experts are warning this isn't just Missouri's problem.
News18
2 hours ago
- News18
Rakesh Roshan Shares Health Update After Neck Angioplasty: ‘Carotid Arteries Were Above 75% Blocked'
Published By : IANS Rakesh Roshan, who underwent neck angioplasty, shared that over 75% of his carotid arteries were blocked, a condition that could have been potentially dangerous if ignored. Veteran filmmaker Rakesh Roshan has shared a health update and said that he by chance found out that although asymptomatic, both his carotid arteries to the brain were blocked over 75 percent. Rakesh took to Instagram, where he shared a picture from the hospital. He also said that the week has been an eye opener for him. He wrote: 'This week has been truly eye opening, during a routine full body health check up the Dr conducting the sonography for the heart suggested I also do one for the neck." 'By chance we found out that although asymptomatic, both my carotid arteries to the brain were above 75% blocked." He said if it was ignored it 'could be potentially dangerous." View this post on Instagram A post shared by Rakesh Roshan (@rakesh_roshan9) 'I immediately admitted myself into the hospital and got the preventative procedures done. I am back home now fully recovered and hope to get back to my workouts very soon. I hope this inspires others to stay on top of their health especially where the heart and brain is concerned." The filmmaker shared that he underwent a 'heart CT and a carotid brain artery sonography ( which is often ignored completely) is a must for everyone above 45- 50 years old." 'I think it's important to remember that prevention is always better than cure. I wish a healthy and aware year to you all," said Rakesh. It was earlier reported that Rakesh, who is the father of Bollywood star Hrithik Roshan, underwent neck angioplasty. On the work front, it was in April, when 'Krrish 4" was announced. Filmmaker Rakesh Roshan announced Hrithik Roshan's directorial debut with 'Krrish 4' as he passed the baton of a franchise that he shaped and nurtured in the past 22 years. The film is being produced by Yash Raj Films in association with Rakesh Roshan. The Indian superstar Hrithik Roshan will be swinging between the two departments of direction and acting for the film as he essays the titular superhero in the franchise. The shooting for the film is set to begin early next year. First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
